Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
08 03 2022
Historique:
pubmed: 11 12 2021
medline: 19 4 2022
entrez: 10 12 2021
Statut: ppublish

Résumé

Identification of patients with nonischemic cardiomyopathy who may benefit from prophylactic implantation of a cardioverter-defibrillator. We hypothesized that periodic repolarization dynamics (PRD), a marker of repolarization instability associated with sympathetic activity, could be used to identify patients who will benefit from prophylactic implantable cardioverter defibrillator (ICD) implantation. We performed a post hoc analysis of DANISH (Danish ICD Study in Patients With Dilated Cardiomyopathy), in which patients with nonischemic cardiomyopathy, left ventricular ejection fraction (LVEF) ≤35%, and elevated NT-proBNP (N-terminal probrain natriuretic peptides) were randomized to ICD implantation or control group. Patients were included in the PRD substudy if they had a 24-hour Holter monitor recording at baseline with technically acceptable ECG signals during the night hours (00:00-06:00). PRD was assessed using wavelet analysis according to previously validated methods. The primary end point was all-cause mortality. Cox regression models were adjusted for age, sex, NT-proBNP, estimated glomerular filtration rate, LVEF, atrial fibrillation, ventricular pacing, diabetes, cardiac resynchronization therapy, and mean heart rate. We proposed PRD ≥10 deg A total of 748 of the 1116 patients in DANISH qualified for the PRD substudy. During a mean follow-up period of 5.1±2.0 years, 82 of 385 patients died in the ICD group and 85 of 363 patients died in the control group ( Increased PRD identified patients with nonischemic cardiomyopathy in whom prophylactic ICD implantation led to significant mortality reduction.

Sections du résumé

BACKGROUND
Identification of patients with nonischemic cardiomyopathy who may benefit from prophylactic implantation of a cardioverter-defibrillator. We hypothesized that periodic repolarization dynamics (PRD), a marker of repolarization instability associated with sympathetic activity, could be used to identify patients who will benefit from prophylactic implantable cardioverter defibrillator (ICD) implantation.
METHODS
We performed a post hoc analysis of DANISH (Danish ICD Study in Patients With Dilated Cardiomyopathy), in which patients with nonischemic cardiomyopathy, left ventricular ejection fraction (LVEF) ≤35%, and elevated NT-proBNP (N-terminal probrain natriuretic peptides) were randomized to ICD implantation or control group. Patients were included in the PRD substudy if they had a 24-hour Holter monitor recording at baseline with technically acceptable ECG signals during the night hours (00:00-06:00). PRD was assessed using wavelet analysis according to previously validated methods. The primary end point was all-cause mortality. Cox regression models were adjusted for age, sex, NT-proBNP, estimated glomerular filtration rate, LVEF, atrial fibrillation, ventricular pacing, diabetes, cardiac resynchronization therapy, and mean heart rate. We proposed PRD ≥10 deg
RESULTS
A total of 748 of the 1116 patients in DANISH qualified for the PRD substudy. During a mean follow-up period of 5.1±2.0 years, 82 of 385 patients died in the ICD group and 85 of 363 patients died in the control group (
CONCLUSIONS
Increased PRD identified patients with nonischemic cardiomyopathy in whom prophylactic ICD implantation led to significant mortality reduction.

Identifiants

pubmed: 34889650
doi: 10.1161/CIRCULATIONAHA.121.056464
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-764

Auteurs

Rune Boas (R)

Department of Cardiology, Amager Hvidovre University Hospital, University of Copenhagen, Denmark (R.B., U.D.).
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Zealand University Hospital Roskilde, Denmark (R.B., N.E.B.).

Nikolay Sappler (N)

University Hospital for Internal Medicine III, Medical University of Innsbruck, Austria (N.S., L.v.S., A. Bauer).

Lukas von Stülpnagel (L)

University Hospital for Internal Medicine III, Medical University of Innsbruck, Austria (N.S., L.v.S., A. Bauer).
Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-University Munich, Germany (L.v.S., M.K., K.D.R.)., German Centre for Cardiovascular Research (DZHK), Germany (L.v.S., M.K., K.D.R.).

Mathias Klemm (M)

Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-University Munich, Germany (L.v.S., M.K., K.D.R.)., German Centre for Cardiovascular Research (DZHK), Germany (L.v.S., M.K., K.D.R.).

Ulrik Dixen (U)

Department of Cardiology, Amager Hvidovre University Hospital, University of Copenhagen, Denmark (R.B., U.D.).
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).

Jens Jakob Thune (JJ)

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Bispebjerg Frederiksberg University Hospital (J.J.T.), University of Copenhagen, Denmark.

Steen Pehrson (S)

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (S.P., L.K., B.T.P., J.H.S., J.T.-H.).

Lars Køber (L)

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (S.P., L.K., B.T.P., J.H.S., J.T.-H.).

Jens C Nielsen (JC)

Departments of Cardiology (J.C.N., H.E.), Aarhus University, Denmark.
Clinical Medicine (J.C.N.), Aarhus University, Denmark.

Lars Videbæk (L)

Department of Medicine, Odense University Hospital, Svendborg, Denmark (L.V.).
Department of Cardiology, Odense University Hospital, Denmark (L.V., A. Brandes).

Jens Haarbo (J)

Department of Cardiology, Herlev Gentofte University Hospital, Copenhagen, Denmark (J.H.).

Eva Korup (E)

Department of Cardiology, Aalborg University Hospital, Denmark (E.K., A.M.T.).

Niels Eske Bruun (NE)

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Zealand University Hospital Roskilde, Denmark (R.B., N.E.B.).

Axel Brandes (A)

Department of Cardiology, Odense University Hospital, Denmark (L.V., A. Brandes).
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense (A. Brandes).

Hans Eiskjær (H)

Departments of Cardiology (J.C.N., H.E.), Aarhus University, Denmark.

Anna M Thøgersen (AM)

Department of Cardiology, Aalborg University Hospital, Denmark (E.K., A.M.T.).

Berit T Philbert (BT)

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (S.P., L.K., B.T.P., J.H.S., J.T.-H.).

Jesper Hastrup Svendsen (JH)

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (R.B., U.D., J.J.T., S.P., L.K., N.E.B., J.H.S.).
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (S.P., L.K., B.T.P., J.H.S., J.T.-H.).

Jacob Tfelt-Hansen (J)

Department of Forensic Medicine, Faculty of Medical Sciences (J.T.-H.), University of Copenhagen, Denmark.
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (S.P., L.K., B.T.P., J.H.S., J.T.-H.).

Axel Bauer (A)

University Hospital for Internal Medicine III, Medical University of Innsbruck, Austria (N.S., L.v.S., A. Bauer).

Konstantinos D Rizas (KD)

Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-University Munich, Germany (L.v.S., M.K., K.D.R.)., German Centre for Cardiovascular Research (DZHK), Germany (L.v.S., M.K., K.D.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH